Alveolus Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Alveolus Bio General Information

Description

Developer of biotherapeutic delivery systems intended to address chronic lung diseases. The company's platform utilizes proprietary inhaled biotherapeutics that target fibroblast dysfunction and neutrophilic inflammation, enabling healthcare providers to improve patient outcomes in respiratory conditions such as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1500 1st Avenue North
  • H102
  • Birmingham, AL 35203
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 1500 1st Avenue North
  • H102
  • Birmingham, AL 35203
  • United States

Alveolus Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alveolus Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 04-Aug-2025 Completed Clinical Trials - Phase 2
4. Accelerator/Incubator 21-Nov-2024 Completed Pre-Clinical Trials
3. Grant 15-Feb-2023 Completed Pre-Clinical Trials
2. Seed Round 26-Oct-2021 $4.5M $4.5M Completed Pre-Clinical Trials
1. Spin-Off 26-Oct-2021 Completed Pre-Clinical Trials
To view Alveolus Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Alveolus Bio Patents

Alveolus Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022415443-A1 Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease Pending 16-Dec-2021
EP-4447951-A2 Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease Pending 16-Dec-2021
EP-4447951-A4 Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease Pending 16-Dec-2021
US-20250041214-A1 Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease Pending 16-Dec-2021
WO-2023114375-A2 Inhalable or ingestible lactic acid compositions for the treatment of chronic lung disease Inactive 16-Dec-2021 A61K9/0075
To view Alveolus Bio’s complete patent history, request access »

Alveolus Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alveolus Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shilpa Medicare Corporation Minority
Station 41 Accelerator/Incubator
NIH Seed Not-For-Profit Venture Capital
Biostack Ventures Accelerator/Incubator Minority
First Avenue Ventures Accelerator/Incubator Minority
To view Alveolus Bio’s complete investors history, request access »

Alveolus Bio FAQs

  • When was Alveolus Bio founded?

    Alveolus Bio was founded in 2020.

  • Where is Alveolus Bio headquartered?

    Alveolus Bio is headquartered in Birmingham, AL.

  • What is the size of Alveolus Bio?

    Alveolus Bio has 8 total employees.

  • What industry is Alveolus Bio in?

    Alveolus Bio’s primary industry is Drug Discovery.

  • Is Alveolus Bio a private or public company?

    Alveolus Bio is a Private company.

  • What is Alveolus Bio’s current revenue?

    The current revenue for Alveolus Bio is .

  • How much funding has Alveolus Bio raised over time?

    Alveolus Bio has raised $4.5M.

  • Who are Alveolus Bio’s investors?

    Shilpa Medicare, Station 41, NIH Seed, Biostack Ventures, and First Avenue Ventures have invested in Alveolus Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process